Results 311 to 320 of about 154,650 (346)
Some of the next articles are maybe not open access.

Pathogenesis of nonalcoholic steatohepatitis

Cellular and Molecular Life Sciences, 2016
Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease and a risk factor for cirrhosis and hepatocellular carcinoma. The pathological features of NASH include steatosis, hepatocyte injury, inflammation, and various degrees of fibrosis. Steatosis reflects disordered lipid metabolism.
Wensheng, Liu   +4 more
openaire   +2 more sources

Non-alcoholic Steatohepatitis in Children

Clinics in Liver Disease, 2003
Non-alcoholic steatohepatitis (NASH) is an important liver disease in children; it can cause cirrhosis in children. The disease mechanism involves hepatic insulin resistance with hyperinsulinemia and changes in certain adipocytokines and inflammatory mediators.
openaire   +3 more sources

Drug-induced steatohepatitis

Clinics in Liver Disease, 2003
Drugs rarely cause steatohepatitis, but amiodarone, perhexiline, and DH, have unequivocally been found to independently induce the histologic picture of alcoholic liver disease or NASH. All three agents have similar pathogenetic mechanisms of hepatotoxicity, targeting mitochondrial ATP production and fatty acid catabolism. Other drugs that occasionally
R Todd, Stravitz, Arun J, Sanyal
openaire   +2 more sources

Fat paradox of steatohepatitis

Journal of Gastroenterology and Hepatology, 2008
AbstractAlcoholic and non‐alcoholic steatohepatitis (ASH and NASH) constitute two major types of chronic liver disease with worldwide prevalence and are histologically indistinguishable with shared pathogenetic mechanisms. More importantly, they have synergistic interactions for liver pathology. Comparative studies on ASH and NASH have been hampered by
Hidekazu, Tsukamoto   +4 more
openaire   +2 more sources

Inflammation and fibrogenesis in steatohepatitis

Journal of Gastroenterology, 2012
Nonalcoholic fatty liver disease consists of a range of disorders characterized by excess accumulation of triglyceride within the liver. Whereas simple steatosis is clinically benign, nonalcoholic steatohepatitis (NASH) often progresses to cirrhosis.
Hideki, Fujii, Norifumi, Kawada
openaire   +2 more sources

Fibrogenesis in nonalcoholic steatohepatitis

Expert Review of Gastroenterology & Hepatology, 2011
Nonalcoholic steatohepatitis includes a wide spectrum of liver injury, ranging from simple inflammation to fibrosis and cirrhosis. Whereas simple steatosis has a benign clinical course, steatohepatitis is a recognized cause of progressive liver fibrosis and can develop, in some circumstances, into cirrhosis.
De Minicis   +2 more
openaire   +3 more sources

Etiopathogenesis of Nonalcoholic Steatohepatitis

Seminars in Liver Disease, 2001
The definable causes of nonalcoholic steatohepatitis (NASH) include jejunoileal bypass surgery (JIB), other causes of rapid and profound weight loss in obese subjects, total parenteral nutrition, drugs, industrial toxins, copper toxicity, and disorders characterized by extreme insulin resistance.
S, Chitturi, G C, Farrell
openaire   +2 more sources

Pathology of nonalcoholic steatohepatitis

Hepatology Research, 2005
To date, histologic evaluation, most commonly in the form of liver biopsy, remains the gold standard in evaluation of nonalcoholic fatty liver disease (NAFLD). Histologic evaluation was fundamental to the initial studies that introduced and defined the concept of fatty liver as a liver disease.
openaire   +2 more sources

Alcoholic and nonalcoholic steatohepatitis

Clinics in Liver Disease, 2002
The constellation of histopathologic lesions that characterize alcoholic and nonalcoholic steatohepatitis has been well described and has served as the basis for clinical diagnosis, natural history studies, and experimental models for analyses of etiopathogenesis.
openaire   +2 more sources

Home - About - Disclaimer - Privacy